Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer-Reference-Cited by-同舟云学术

Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer

Published:1998-10 Issue:1 Volume:22 Page:31-38
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Martoni A,Guaraldi M,Piana E,Strocchi E,Petralia A,Busutti L,Preti P,Robustelli della Cuna G,Raimondi M,Ferrara G,Palomba G,Lelli G,Picece V,Recaldin E,Caffo O,Ambrosini G,Sarobba G,Farris A,Pannuti F

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;Non-Small Cell Lung Cancer Collaborative Group;Br Med J,1995

2. A phase II study of Navelbine (vinorelbine) in the treatment of non-small cell lung cancer;Depierre;Am J Clin Oncol,1991

3. Randomized study of Vinorelbine and Cisplatin versus Vindesine and Cisplatin versus Vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients;Le Chevalier;J Clin Oncol,1994

4. Phase II trial of 4′Epi-doxorubicin in patients with non-small cell lung cancer;Kalman;Cancer Treat Rep,1983

5. Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung;Joss;Eur J Cancer Clin Oncol,1984

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Arrhythmia Risk after Anti-Cancer Drug Exposure and Related Disease Molecular Imaging Outlook: A Systematic Review, Meta-Analysis, and Network Meta-Analysis;Biology;2024-06-25

2. QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics;Current Treatment Options in Oncology;2019-05-25

3. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review;Journal of the American Heart Association;2017-12-02

4. Long-term Results of a Pilot Study on an Intensive Induction Regimen for Unresectable Stage III Non-Small-Cell Lung Cancer;Tumori Journal;2010-01

5. Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial;Lung Cancer;2008-12